|
Field Safety Notices: 4 to 8 August 2025
|
Field Safety Notices
|
12 Aug 2025 |
|
|
Field Safety Notices: 28 July to 1 August 2025
|
Field Safety Notices
|
5 Aug 2025 |
|
|
MHRA Safety Roundup: July 2025
|
Alerts and Recalls for Drugs and Medical Devices - General Practice
|
31 Jul 2025 |
|
|
Field Safety Notices: 21 to 25 July 2025
|
Field Safety Notices
|
30 Jul 2025 |
|
|
Class 2 Medicines Recall: ChloraPrep 1mL Clear Sterile Solution/Applicator, Becton Dickinson UK Ltd, EL(25)A/36
|
Alerts and Recalls for Drugs and Medical Devices - General Practice
|
28 Jul 2025 |
|
|
Trinity Biotech Premier Hb9210™ HbA1c Analyser: Risk of Positive Bias and Updates to Instructions for Use (IFU), including use as a diagnostic aid in diabetes mellitus (DSI/2025/003)
|
Alerts and Recalls for Drugs and Medical Devices - General Practice
|
22 Jul 2025 |
|
|
Field Safety Notices: 14 to 18 July 2025
|
Field Safety Notices
|
22 Jul 2025 |
|
|
Field Safety Notices: 7 to 11 July 2025
|
Field Safety Notices
|
21 Jul 2025 |
|
|
Field Safety Notices: 30 June to 4 July 2025
|
Field Safety Notices
|
8 Jul 2025 |
|
|
Class 3 Medicines Recall: Omeprazole 20 mg/15 ml Oral Solution, Glenmark Pharmaceuticals Europe Ltd, EL(25)A/30
|
Alerts and Recalls for Drugs and Medical Devices - General Practice
|
30 Jun 2025 |
|
|
Class 2 Medicines Recall: Depo-Medrone 80 mg in 2 mL, Maxearn Limited EL(25)A/29
|
Alerts and Recalls for Drugs and Medical Devices - General Practice
|
25 Jun 2025 |
|
|
MHRA Safety Roundup: June 2025
|
Alerts and Recalls for Drugs and Medical Devices - General Practice
|
24 Jun 2025 |
|
|
MHRA Safety Roundup: May 2025
|
Alerts and Recalls for Drugs and Medical Devices - General Practice
|
13 Jun 2025 |
|
|
Philips Respironics BiPAP A series ventilators: alarm malfunction and risk of therapy interruptions in ventilators not intended for life-support, DSI/2024/006
|
Alerts and Recalls for Drugs and Medical Devices - General Practice
|
23 May 2025 |
|
|
MHRA Safety Roundup: April 2025
|
Alerts and Recalls for Drugs and Medical Devices - General Practice
|
29 Apr 2025 |
|
|
Class 2 Medicines Recall: Lercanidipine HCl 20mg Tablets, Recordati Industria, EL(25)A/17
|
Alerts and Recalls for Drugs and Medical Devices - General Practice
|
17 Apr 2025 |
|
|
Class 2 Medicines Recall: Synalar GEL 30g, Synalar GEL 60g,(fluocinolone acetonide 0.025%) Reig Jofre UK,EL(25)A/16
|
Alerts and Recalls for Drugs and Medical Devices - General Practice
|
8 Apr 2025 |
|
|
Class 4 Medicines Defect Notification: Renacet 475 mg and 950 mg Tablets (calcium acetate), RenaCare NephroMed GmbH, EL(25)A15
|
Alerts and Recalls for Drugs and Medical Devices - General Practice
|
7 Apr 2025 |
|
|
Class 3 Medicines Recall: Urospir 50mg/5ml Oral Solution, EL(25)A/14
|
Alerts and Recalls for Drugs and Medical Devices - General Practice
|
2 Apr 2025 |
|
|
Class 2 Medicines Recall: Utrogestan Vaginal 200 mg Capsules (progesterone), EL(25)A/13
|
Alerts and Recalls for Drugs and Medical Devices - General Practice
|
1 Apr 2025 |
|
|
Class 2 Medicines Recall: Sun Pharmaceutical Industries Europe B.V., Pemetrexed 1000MG/100ML (10mg/ml) & 800MG/100ML (8mg/ml) Infusion bag, EL(25)A/09
|
Alerts and Recalls for Drugs and Medical Devices - General Practice
|
4 Mar 2025 |
|
|
Class 2 Medicines Recall: Boots Paracetamol 500 mg tablets (16s), EL(25)A/10
|
Alerts and Recalls for Drugs and Medical Devices - General Practice
|
4 Mar 2025 |
|
|
Class 3 Medicines Recall: Azacitidine 100 mg/vial and 150 mg/vial Powder for Suspension for Injection, EL(25)A/08
|
Alerts and Recalls for Drugs and Medical Devices - General Practice
|
3 Mar 2025 |
|
|
Class 3 Medicines Recall: Glucophage SR 500 mg, 750mg and 1000mg Prolonged-release Tablets, EL(25)A/07
|
Alerts and Recalls for Drugs and Medical Devices - General Practice
|
20 Feb 2025 |
|
|
Class 4 Medicines Notification: Lansoprazole Gastro-resistant Hard Capsules 15mg, EL(25)A/06
|
Alerts and Recalls for Drugs and Medical Devices - General Practice
|
11 Feb 2025 |
|
|
Class 2 Medicines Recall: Nitrofurantoin CNX Therapeutics 100 mg Prolonged-Release capsules, EL(25)A/05
|
Alerts and Recalls for Drugs and Medical Devices - General Practice
|
5 Feb 2025 |
|
|
Class 2 Medicines Recall: Bristol Laboratories Limited, Amlodipine Bristol Lab 2.5 mg Tablets, EL (25)A/04
|
Alerts and Recalls for Drugs and Medical Devices - General Practice
|
30 Jan 2025 |
|
|
UPDATE: Class 2 Medicines Recall: Tesco Health Dry Cough Relief 200ml, Asda Strong Dry Tickly Cough 200ml, Almus Dry Cough Relief & Bells Dual Action Dry Cough, EL(25)A/03
|
Alerts and Recalls for Drugs and Medical Devices - General Practice
|
22 Jan 2025 |
|
|
Class 4 Medicines Notification: Irbesartan 150 mg and 300 mg film-coated tablets, EL(25)A/02
|
Alerts and Recalls for Drugs and Medical Devices - General Practice
|
13 Jan 2025 |
|
|
Class 4 Medicines Notification: Rabeprazole sodium 10mg and 20mg gastro-resistant tablets, EL(25)A/01
|
Alerts and Recalls for Drugs and Medical Devices - General Practice
|
9 Jan 2025 |
|
|
Class 4 Medicines Notification: Argenx BV, Vyvgart 1000 mg solution for injection, EL (24)A/63
|
Alerts and Recalls for Drugs and Medical Devices - General Practice
|
19 Dec 2024 |
|
|
Class 2 Medicines Recall: Wockhardt UK Limited, WockAIR 160 microgram/4.5 microgram, inhalation powder, EL(24)A/62
|
Alerts and Recalls for Drugs and Medical Devices - General Practice
|
9 Dec 2024 |
|
|
Class 4 Medicines Defect Information: Brillpharma Limited, Oxybutynin hydrochloride Brillpharma 2.5 mg/5 ml Oral Solution, EL(24)A/61
|
Alerts and Recalls for Drugs and Medical Devices - General Practice
|
4 Dec 2024 |
|
|
Class 3 Medicines Recall: Kent Pharma UK, Phenoxymethylpenicillin 250mg/5ml Oral Solution Sugar Free, EL (24)A/60
|
Alerts and Recalls for Drugs and Medical Devices - General Practice
|
3 Dec 2024 |
|
|
Class 4 Medicines Defect Information: Rosemont Pharmaceuticals Limited, Mycophenolate Mofetil 1g/5ml Oral Suspension, EL(24)A/59
|
Alerts and Recalls for Drugs and Medical Devices - General Practice
|
2 Dec 2024 |
|
|
Class 4 Medicines Defect Information: Strides Pharma UK Ltd, Liothyronine Sodium 5 & 20 micrograms Tablets, EL(24)A/58
|
Alerts and Recalls for Drugs and Medical Devices - General Practice
|
28 Nov 2024 |
|
|
National Patient Safety Alert: Reducing risks for transfusion-associated circulatory overload (NatPSA/2024/004/MHRA)
|
National patient safety alert
|
4 Apr 2024 |
|
|
National Patient Safety Alert: Valproate: organisations to prepare for new regulatory measures for oversight of prescribing to new patients and existing female patients (NatPSA/2023/013/MHRA)
|
National patient safety alert
|
28 Nov 2023 |
|
|
National Patient Safety Alert: Medical beds, trolleys, bed rails, bed grab handles and lateral turning devices: risk of death from entrapment or falls (NatPSA/2023/010/MHRA)
|
National patient safety alert
|
30 Aug 2023 |
|
|
National Patient Safety Alert: Potential risk of underdosing with calcium gluconate in severe hyperkalaemia (NatPSA/2023/007/MHRA)
|
National patient safety alert
|
27 Jun 2023 |
|
|
National Patient Safety Alert: Removal of Philips Health Systems V60 and V60 Plus ventilators from service: risk of shutdown leading to complete loss of ventilation (NatPSA/2023/005/MHRA)
|
National patient safety alert
|
18 May 2023 |
|
|
National Patient Safety Alert: Class 1 Medicines Recall Notification: Recall of Emerade 500 micrograms and Emerade 300 micrograms auto-injectors, due to the potential for device failure, NatPSA/2023/004/MHRA
|
National patient safety alert
|
9 May 2023 |
|
|
National Patient Safety Alert: NIDEK EyeCee One preloaded and EyeCee One Crystal preloaded Intraocular Lenses (IOLs): risk of increased intraocular pressure (NatPSA/2023/003/MHRA)
|
National patient safety alert
|
1 Feb 2023 |
|
|
National Patient Safety Alert: Class 1 Medicines Recall Notification: Recall of Targocid 200mg powder for solution for injection/infusion or oral solution, Aventis Pharma Limited t/a Sanofi, due to the presence of bacterial endotoxins, NatPSA/2022/008/MHRA
|
National patient safety alert
|
21 Oct 2022 |
|
|
National Patient Safety Alert: Class 1 Medicines Recall Notification: Recall of Mexiletine hydrochloride 50mg, 100mg and 200 mg Hard Capsules, Clinigen Healthcare Ltd, due to a potential for underdosing and/or overdosing, NatPSA/2022/007/MHRA
|
National patient safety alert
|
4 Aug 2022 |
|
|
National Patient Safety Alert: Philips Health Systems V60, V60 Plus and V680 ventilators: potential unexpected shutdown leading to complete loss of ventilation (NatPSA/2022/002/MHRA)
|
National patient safety alert
|
29 Jul 2022 |
|
|
National Patient Safety Alert: NovoRapid PumpCart in the Roche Accu-Chek Insight insulin pump: risk of insulin leakage causing hyperglycaemia and diabetic ketoacidosis (NatPSA/2022/004/MHRA)
|
National patient safety alert
|
26 May 2022 |
|
|
National Patient Safety Alert: Philips ventilator, CPAP and BiPAP devices: Potential for patient harm due to inhalation of particles and volatile organic compounds (NatPSA/2021/005/MHRA)
|
National patient safety alert
|
23 Jun 2021 |
|
|
National Patient Safety Alert: Class 1 Medicines Recall Notification: Recall of Co-codamol 30/500 Effervescent Tablets, Batch 1K10121, Zentiva Pharma UK Ltd, due to precautionary risk of causing overdose, NatPSA/2021/004/MHRA
|
National patient safety alert
|
16 Jun 2021 |
|
|
National Patient Safety Alert: Supply disruption of sterile infusion sets and connectors manufactured by Becton Dickinson (BD) (NatPSA/2021/001/MHRA)
|
National patient safety alert
|
11 Mar 2021 |
|